UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 14, 2022
Accession Number:
Submission Type:
CIK:
0001536196
Company Name:
Can-Fite BioPharma Ltd.
File Number:
333-262055